Tego Science (XKRX:191420) Debt-to-Asset : 0.03 (As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Tego Science Debt-to-Asset?

Tego Science's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩1,435 Mil. Tego Science's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩322 Mil. Tego Science's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2024 was ₩52,515 Mil. Tego Science's debt to asset for the quarter that ended in Dec. 2024 was 0.03.

Tego Science Debt-to-Asset Historical Data

The historical data trend for Tego Science's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tego Science Debt-to-Asset Chart

Tego Science Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Debt-to-Asset

Get a 7-Day Free Trial

0.02

0.03

Tego Science Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Debt-to-Asset	Get a 7-Day Free Trial															0.03	0.03	0.03	0.03	0.03

Competitive Comparison of Tego Science's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Tego Science's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tego Science's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tego Science's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Tego Science's Debt-to-Asset falls into.

Save Embed

;

Save Embed

;

Tego Science Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Tego Science's Debt-to-Asset for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(1435.099	+	321.835)	/	52515.371
	=	0.03

Tego Science's Debt-to-Asset for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(1435.099	+	321.835)	/	52515.371
	=	0.03

Tego Science (XKRX:191420) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Tego Science Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Tego Science's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Tego Science Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tego Science Inc (XKRX:191420) » Definitions » Debt-to-Asset

Traded in Other Exchanges

N/A

Address

8, Maagok central, gangseo-gu, Seoul, KOR

Website

http://www.tegoscience.com

Tego Science Inc is a biotech company that researches and develops regenerative medicine. It is engaged in the production of epidermis and cornea wound healing solution. Its products include Holoderm, SkinBank, Kaloderm, and Neoderm. It also provides testing services.

Tego Science Headlines

No Headlines